Valion Bio, Inc. (VBIO)

CIK 1787740 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Valion Bio, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001683168-26-008352
Nov 2, 20268-K0001683168-26-008221
Oct 29, 20268-K0001437749-26-033850
Oct 27, 20268-K0001437749-26-033552
Oct 26, 20268-K0001437749-26-033460
Oct 22, 20268-K0001437749-26-033175
Oct 21, 2026424B30001683168-26-007998
Oct 20, 2026EFFECT9999999995-26-003301
Oct 20, 2026EFFECT9999999995-26-003309
Oct 16, 2026DEF 14A0001683168-26-007932
Oct 16, 2026S-30001683168-26-007936
Oct 15, 20268-K0001683168-26-007857
Oct 14, 20268-K0001683168-26-007834
Oct 8, 20268-K0001683168-26-007709
Oct 8, 2026S-30001683168-26-007707
Oct 6, 20268-K0001437749-26-032107
Oct 2, 2026PRE 14A0001683168-26-007588
Oct 1, 20268-K0001683168-26-007514
Sep 24, 202640001683168-26-007398
Sep 24, 202640001683168-26-007396
Sep 23, 20268-K0001683168-26-007300
Sep 17, 202630001683168-26-007216
Sep 17, 202630001683168-26-007217
Sep 4, 2026SCHEDULE 13G/A0001753926-26-001726
Sep 3, 2026SCHEDULE 13D/A0001753926-26-001719